News & Updates
Filter by Specialty:
JAK inhibitors shown safe, effective in RA patients
A recent study has demonstrated the safety and efficacy of oral Janus kinase (JAK) inhibitors in patients with rheumatoid arthritis (RA) in the real-world setting, particularly in those who do not present with cardiovascular risk factors at baseline.
JAK inhibitors shown safe, effective in RA patients
11 Dec 2023
One in six CYPs in SG develop long COVID
In Singapore, about one in six children and young persons (CYPs) developed long COVID, with persistence of ≥1 symptoms 3 months after an acute COVID-19 infection, a survey study suggests.
One in six CYPs in SG develop long COVID
11 Dec 2023
Light therapy associated with improved sleep and psychobehavioural symptoms in Alzheimer’s disease
A meta-analysis of 15 randomized controlled trials (RCTs) finds that light therapy significantly improves sleep efficiency, alleviates depression and reduces agitation in patients with Alzheimer’s disease (AD), as well as lessens caregiver burden.
Light therapy associated with improved sleep and psychobehavioural symptoms in Alzheimer’s disease
09 Dec 2023
Transcranial direct current stimulation improves social functioning in autism spectrum disorder
A double-blind, sham-controlled study by researchers from the Hong Kong Polytechnic University shows that cathodal transcranial direct current stimulation (tDCS) of the left dorsolateral prefrontal cortex (dlPFC) paired with cognitive remediation is a feasible and effective treatment for improving social functioning and information processing in adolescents and young adults with autism spectrum disorder (ASD) who have average to borderline IQ.
Transcranial direct current stimulation improves social functioning in autism spectrum disorder
09 Dec 2023
Myeloma patients may benefit from mezigdomide-dexamethasone doublet
In a study evaluating heavily pretreated patients with relapsed and refractory multiple myeloma (R/R MM), the combination of mezigdomide and dexamethasone showed promising preliminary efficacy, with myelosuppression and infection as primary toxicities.
